Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1988 Oct 22;297(6655):1024–1026. doi: 10.1136/bmj.297.6655.1024

Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome.

R Homburg 1, N A Armar 1, A Eshel 1, J Adams 1, H S Jacobs 1
PMCID: PMC1834779  PMID: 3142595

Abstract

Women with the polycystic ovary syndrome do not respond well to treatment with luteinising hormone releasing hormone. To determine whether this might be due to an underlying endocrine disturbance basal concentrations of luteinising hormone were measured in 54 infertile women treated with pulsatile luteinising hormone releasing hormone and concentrations at the time of maximum follicular growth were measured in 23 of the patients. Forty one patients ovulated. Forty one patients ovulated and 27 conceived, but nine pregnancies terminated within four weeks after ovulation. Basal luteinising hormone concentrations were significantly lower in those who conceived (12.4 (range 1.3-29.0) IU/l) than in those who did not (19.0 (3.5-50.0) IU/l) and in those whose pregnancy progressed (9.6 (1.3-29.0) IU/l) than in those with early loss of pregnancy (17.9 (7.0-29.0) IU/l). Concentrations at the time of maximum follicular growth were significantly lower in women who ovulated (9.4 (2.9-35.4) IU/l) than in those who did not (29.0 (7.0-50.0) IU/l) and in those who conceived (6.2 (2.9-8.5) IU/l) than in those who did not (17.9 (4.0-50.0) IU/l). These results indicate that high concentrations of luteinising hormone during the follicular phase in women with polycystic ovaries have a deleterious effect on rates of conception and may be a causal factor in early pregnancy loss.

Full text

PDF
1024

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdulwahid N. A., Adams J., van der Spuy Z. M., Jacobs H. S. Gonadotrophin control of follicular development. Clin Endocrinol (Oxf) 1985 Dec;23(6):613–626. doi: 10.1111/j.1365-2265.1985.tb01122.x. [DOI] [PubMed] [Google Scholar]
  2. Adams J., Franks S., Polson D. W., Mason H. D., Abdulwahid N., Tucker M., Morris D. V., Price J., Jacobs H. S. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet. 1985 Dec 21;2(8469-70):1375–1379. doi: 10.1016/s0140-6736(85)92552-8. [DOI] [PubMed] [Google Scholar]
  3. Adams J., Polson D. W., Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed) 1986 Aug 9;293(6543):355–359. doi: 10.1136/bmj.293.6543.355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Eshel A., Abdulwahid N. A., Armar N. A., Adams J. M., Jacobs H. S. Pulsatile luteinizing hormone-releasing hormone therapy in women with polycystic ovary syndrome. Fertil Steril. 1988 Jun;49(6):956–960. doi: 10.1016/s0015-0282(16)59943-9. [DOI] [PubMed] [Google Scholar]
  5. Guerrero R., Rojas O. I. Spontaneous abortion and aging of human ova and spermatozoa. N Engl J Med. 1975 Sep 18;293(12):573–575. doi: 10.1056/NEJM197509182931202. [DOI] [PubMed] [Google Scholar]
  6. Howles C. M., Macnamee M. C., Edwards R. G., Goswamy R., Steptoe P. C. Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation. Lancet. 1986 Aug 30;2(8505):521–522. doi: 10.1016/s0140-6736(86)90395-8. [DOI] [PubMed] [Google Scholar]
  7. Hunter R. H., Cook B., Baker T. G. Dissociation of response to injected gonadotropin between the Graafian follicle and oocyte in pigs. Nature. 1976 Mar 11;260(5547):156–158. doi: 10.1038/260156a0. [DOI] [PubMed] [Google Scholar]
  8. Mason P., Adams J., Morris D. V., Tucker M., Price J., Voulgaris Z., Van der Spuy Z. M., Sutherland I., Chambers G. R., White S. Induction of ovulation with pulsatile luteinising hormone releasing hormone. Br Med J (Clin Res Ed) 1984 Jan 21;288(6412):181–185. doi: 10.1136/bmj.288.6412.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. McARTHUR J. W., INGERSOLL F. M., WORCESTER J. The urinary excretion of interstitial-cell and follicle-stimulating hormone activity by women with diseases of the reproductive system. J Clin Endocrinol Metab. 1958 Nov;18(11):1202–1215. doi: 10.1210/jcem-18-11-1202. [DOI] [PubMed] [Google Scholar]
  10. Polson D. W., Adams J., Wadsworth J., Franks S. Polycystic ovaries--a common finding in normal women. Lancet. 1988 Apr 16;1(8590):870–872. doi: 10.1016/s0140-6736(88)91612-1. [DOI] [PubMed] [Google Scholar]
  11. Punnonen R., Ashorn R., Vilja P., Heinonen P. K., Kujansuu E., Tuohimaa P. Spontaneous luteinizing hormone surge and cleavage of in vitro fertilized embryos. Fertil Steril. 1988 Mar;49(3):479–482. doi: 10.1016/s0015-0282(16)59776-3. [DOI] [PubMed] [Google Scholar]
  12. Stanger J. D., Yovich J. L. Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynaecol. 1985 Apr;92(4):385–393. doi: 10.1111/j.1471-0528.1985.tb01113.x. [DOI] [PubMed] [Google Scholar]
  13. Tsafriri A., Pomerantz S. H. Oocyte maturation inhibitor. Clin Endocrinol Metab. 1986 Feb;15(1):157–170. doi: 10.1016/s0300-595x(86)80047-0. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES